Uso combinato di PRP ed Acido ialuronico per il trattamento infiltrativo di pazienti con osteoartrite di ginocchio

Title

Code

PRP+HA-23

Type

Sperimentale

Start Year

2024

Status

In Corso

Principal Investigator

051-6366567

davide.reale@ior.it

Reale Davide, MD

Rizzoli-Argenta Orthopaedics and Traumatology

Operational unit that carry out the study

complex unit

Ortopedia e Traumatologia Rizzoli-Argenta

Director

Romagnoli Matteo, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. PRP+HA-23

Wednesday 25 September 2024, 16:24

PG0013884_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Uso combinato di PRP ed Acido ialuronico per il trattamento infiltrativo di pazienti con osteoartrite di ginocchio

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Uso combinato di PRP ed Acido ialuronico per il trattamento infiltrativo di pazienti con osteoartrite di ginocchio

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in